Reduced levels of Dex-induced phospho-Hsl, phospho-Plin1, catalytic and regulatory subunits of PKA [57]. Improved Dex-induced hepatic steatosis and hypertriglyceridemia [57]. The gene discussed is PLIN1; the disease is fatty liver disease.